Fig. 3.
Fig. 3. The threshold effect of progenitor cell dose on hematopoietic reconstitution after mobilized blood cell autotransplants in the authors' institution. In (A) and (B), patients were categorized into those receiving <15, 15 to 49.9, and ≥50 × 104 CFU-GM/kg BW. In (A) the probability of reaching 0.5 × 109 neutrophils/L (N500) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The number of patients in the three categories were 47, 142, and 88, respectively. The differences between the three categories were significant (P < .0001, log-rank test). In (B) the probability of reaching 50 × 109 platelets/L (P50) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The number of patients in the three categories were 45, 131, and 86, respectively. The differences between the three categories were significant (P < .0001, log-rank test). / In (C) and (D) patients were categorized into those receiving <1.5, 1.5 to 4.9, and ≥5 × 106 CD34+ cells/kg BW. The number of patients in these three categories were 39, 53, and 31, respectively. In (C) the probability of reaching 0.5 × 109 neutrophils/L (N500) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The differences between the three categories were not significant (P = .29, log-rank test). In (D) the probability of reaching 50 × 109 platelets/L (P50) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The number of patients in these three categories were 35, 49, and 27, respectively. The differences between the three categories were significant (P = .0052, log-rank test).

The threshold effect of progenitor cell dose on hematopoietic reconstitution after mobilized blood cell autotransplants in the authors' institution. In (A) and (B), patients were categorized into those receiving <15, 15 to 49.9, and ≥50 × 104 CFU-GM/kg BW. In (A) the probability of reaching 0.5 × 109 neutrophils/L (N500) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The number of patients in the three categories were 47, 142, and 88, respectively. The differences between the three categories were significant (P < .0001, log-rank test). In (B) the probability of reaching 50 × 109 platelets/L (P50) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The number of patients in the three categories were 45, 131, and 86, respectively. The differences between the three categories were significant (P < .0001, log-rank test).

In (C) and (D) patients were categorized into those receiving <1.5, 1.5 to 4.9, and ≥5 × 106 CD34+ cells/kg BW. The number of patients in these three categories were 39, 53, and 31, respectively. In (C) the probability of reaching 0.5 × 109 neutrophils/L (N500) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The differences between the three categories were not significant (P = .29, log-rank test). In (D) the probability of reaching 50 × 109 platelets/L (P50) for each of these three categories was denoted by the lines - - -, — , ⋅⋅⋅, respectively. The number of patients in these three categories were 35, 49, and 27, respectively. The differences between the three categories were significant (P = .0052, log-rank test).

Close Modal

or Create an Account

Close Modal
Close Modal